159 related articles for article (PubMed ID: 29560661)
1. HLA DPB1 15:01 Allele Predicts Spontaneus Hepatitis B Surface Antigen Seroconversion.
Katrinli S; Nilay Karatas Erkut G; Ozdil K; Yilmaz Enc F; Ozturk O; Kahraman R; Tuncer I; Dinler Doganay G; Doganay L
Acta Gastroenterol Belg; 2017; 80(3):351-355. PubMed ID: 29560661
[TBL] [Abstract][Full Text] [Related]
2. Association between chronic hepatitis B virus infection and HLA-DP gene polymorphisms in the Turkish population.
Akgöllü E; Bilgin R; Akkız H; Ülger Y; Kaya BY; Karaoğullarından Ü; Arslan YK
Virus Res; 2017 Mar; 232():6-12. PubMed ID: 28119119
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of HLA-DPA1/DPB1 variants against Hepatitis B virus infection in an Indonesian population.
Wasityastuti W; Yano Y; Ratnasari N; Triyono T; Triwikatmani C; Indrarti F; Heriyanto DS; Yamani LN; Liang Y; Utsumi T; Hayashi Y
Infect Genet Evol; 2016 Jul; 41():177-184. PubMed ID: 27051043
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA-DPA1 and HLA-DPB1 polymorphisms with spontaneous HBsAg seroclearance in Caucasians.
Koukoulioti E; Fischer J; Schott E; Fülöp B; Heyne R; Berg T; van Bömmel F
Liver Int; 2019 Apr; 39(4):646-654. PubMed ID: 30471179
[TBL] [Abstract][Full Text] [Related]
5. Effects of HLA-DPB1 genotypes on chronic hepatitis B infection in Japanese individuals.
Nishida N; Ohashi J; Sugiyama M; Tsuchiura T; Yamamoto K; Hino K; Honda M; Kaneko S; Yatsuhashi H; Koike K; Yokosuka O; Tanaka E; Taketomi A; Kurosaki M; Izumi N; Sakamoto N; Eguchi Y; Sasazuki T; Tokunaga K; Mizokami M
Tissue Antigens; 2015 Dec; 86(6):406-12. PubMed ID: 26449183
[TBL] [Abstract][Full Text] [Related]
6. Fine mapping analysis of HLA-DP/DQ gene clusters on chromosome 6 reveals multiple susceptibility loci for HBV infection.
Tao J; Su K; Yu C; Liu X; Wu W; Xu W; Jiang B; Luo R; Yao J; Zhou J; Zhan Y; Ye C; Yuan W; Jiang X; Cui W; Li MD; Li L
Amino Acids; 2015 Dec; 47(12):2623-34. PubMed ID: 26197724
[TBL] [Abstract][Full Text] [Related]
7. HLA-DP and IL28B polymorphisms: influence of host genome on hepatitis B surface antigen seroclearance in chronic hepatitis B.
Seto WK; Wong DK; Kopaniszen M; Proitsi P; Sham PC; Hung IF; Fung J; Lai CL; Yuen MF
Clin Infect Dis; 2013 Jun; 56(12):1695-703. PubMed ID: 23449268
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B.
Brouwer WP; Sonneveld MJ; Tabak F; Simon K; Cakaloglu Y; Akarca US; Zeuzem S; Ferenci P; Heathcote JE; de Knegt RJ; Boonstra A; Hansen BE; Janssen HL
Aliment Pharmacol Ther; 2014 Oct; 40(7):811-8. PubMed ID: 25109699
[TBL] [Abstract][Full Text] [Related]
9. Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients.
Cheng HR; Liu CJ; Tseng TC; Su TH; Yang HI; Chen CJ; Kao JH
PLoS One; 2013; 8(1):e53008. PubMed ID: 23326374
[TBL] [Abstract][Full Text] [Related]
10. Association between single-nucleotide polymorphisms and early spontaneous hepatitis B virus e antigen seroconversion in children.
Komatsu H; Murakami J; Inui A; Tsunoda T; Sogo T; Fujisawa T
BMC Res Notes; 2014 Nov; 7():789. PubMed ID: 25376093
[TBL] [Abstract][Full Text] [Related]
11. Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis.
Nishida N; Ohashi J; Khor SS; Sugiyama M; Tsuchiura T; Sawai H; Hino K; Honda M; Kaneko S; Yatsuhashi H; Yokosuka O; Koike K; Kurosaki M; Izumi N; Korenaga M; Kang JH; Tanaka E; Taketomi A; Eguchi Y; Sakamoto N; Yamamoto K; Tamori A; Sakaida I; Hige S; Itoh Y; Mochida S; Mita E; Takikawa Y; Ide T; Hiasa Y; Kojima H; Yamamoto K; Nakamura M; Saji H; Sasazuki T; Kanto T; Tokunaga K; Mizokami M
Sci Rep; 2016 Apr; 6():24767. PubMed ID: 27091392
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism and decreased expression of HLA class II DP genes are associated with HBV reactivation in patients treated with immunomodulatory agents.
Matsuda H; Hiramatsu K; Akazawa Y; Nosaka T; Saito Y; Ozaki Y; Hayama R; Takahashi K; Naito T; Ofuji K; Ohtani M; Nemoto T; Hida Y; Kimura H; Soya Y; Nakamoto Y
J Med Virol; 2018 Apr; 90(4):712-720. PubMed ID: 29283185
[TBL] [Abstract][Full Text] [Related]
13. GWAS identifying HLA-DPB1 gene variants associated with responsiveness to hepatitis B virus vaccination in Koreans: Independent association of HLA-DPB1*04:02 possessing rs1042169 G - rs9277355 C - rs9277356 A.
Chung S; Roh EY; Park B; Lee Y; Shin S; Yoon JH; Song EY
J Viral Hepat; 2019 Nov; 26(11):1318-1329. PubMed ID: 31243853
[TBL] [Abstract][Full Text] [Related]
14. Association of human leukocyte antigen DP/DQ gene polymorphisms with chronic hepatitis B in Chinese Han and Uygur populations.
Xiang X; Guo Y; Yang L; Ge Q; Mijit S; Xu F
Infect Genet Evol; 2016 Sep; 43():407-11. PubMed ID: 27291710
[TBL] [Abstract][Full Text] [Related]
15. Role of HLA-DP and HLA-DQ on the clearance of hepatitis B virus and the risk of chronic infection in a multiethnic population.
Trinks J; Nishida N; Hulaniuk ML; Caputo M; Tsuchiura T; Marciano S; Haddad L; Blejer J; Bartoli S; Ameigeiras B; Frías SE; Vistarini C; Heinrich F; Remondegui C; Ceballos S; Echenique G; Charre Samman M; D'Amico C; Rojas A; Martínez A; Ridruejo E; Fernández RJ; Burgos Pratx L; Salamone H; Nuñez F; Galdame O; Gadano A; Corach D; Sugiyama M; Flichman D; Tokunaga K; Mizokami M
Liver Int; 2017 Oct; 37(10):1476-1487. PubMed ID: 28267888
[TBL] [Abstract][Full Text] [Related]
16. SNP rs7770370 in HLA-DPB1 loci as a major genetic determinant of response to booster hepatitis B vaccination: results of a genome-wide association study.
Wu TW; Chen CF; Lai SK; Lin HH; Chu CC; Wang LY
J Gastroenterol Hepatol; 2015 May; 30(5):891-9. PubMed ID: 25389088
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between human leukocyte antigen polymorphisms rs9277535 and rs7453920 and chronic hepatitis B in a Brazilian population.
Pereira VRZB; Wolf JM; Stumm GZ; Boeira TR; Galvan J; Simon D; Lunge VR
Genet Mol Res; 2017 May; 16(2):. PubMed ID: 28613373
[TBL] [Abstract][Full Text] [Related]
18. Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver.
O'Brien TR; Kohaar I; Pfeiffer RM; Maeder D; Yeager M; Schadt EE; Prokunina-Olsson L
Genes Immun; 2011 Sep; 12(6):428-33. PubMed ID: 21346778
[TBL] [Abstract][Full Text] [Related]
19. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
20. Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy.
Tseng TC; Yu ML; Liu CJ; Lin CL; Huang YW; Hsu CS; Liu CH; Kuo SF; Pan CJ; Yang SS; Su CW; Chen PJ; Chen DS; Kao JH
Antivir Ther; 2011; 16(5):629-37. PubMed ID: 21817184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
